My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 279

    1.

    Neoadjuvant chemotherapy for extensive unilateral retinoblastoma.

    Bellaton E, Bertozzi AI, Behar C, Chastagner P, Brisse H, Sainte-Rose C, Doz F, Desjardins L.

    Br J Ophthalmol. 2003 Mar;87(3):327-9.PMID: 12598448 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma.

    Beck MN, Balmer A, Dessing C, Pica A, Munier F.

    J Clin Oncol. 2000 Aug;18(15):2881-7.PMID: 10920136 [PubMed - indexed for MEDLINE]Related articles

    3.

    Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.

    Mustafa MM, Jamshed A, Khafaga Y, Mourad WA, Al-Mesfer S, Kofide A, El-Husseiny G, Gray A.

    J Pediatr Hematol Oncol. 1999 Sep-Oct;21(5):364-9.PMID: 10524448 [PubMed - indexed for MEDLINE]Related articles

    4.

    Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.

    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.

    Pediatr Blood Cancer. 2007 Sep;49(3):256-60.PMID: 17029248 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of overt extraocular retinoblastoma.

    Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E.

    Med Pediatr Oncol. 2003 Mar;40(3):158-61.PMID: 12518344 [PubMed - indexed for MEDLINE]Related articles

    6.

    Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?

    Chantada GL, Dunkel IJ, de Dávila MT, Abramson DH.

    Br J Ophthalmol. 2004 Aug;88(8):1069-73.PMID: 15258027 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Results of a prospective study for the treatment of retinoblastoma.

    Chantada G, Fandiño A, Dávila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E.

    Cancer. 2004 Feb 15;100(4):834-42.PMID: 14770442 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results.

    Levy C, Doz F, Quintana E, Pacquement H, Michon J, Schlienger P, Validire P, Asselain B, Desjardins L, Zucker JM.

    Br J Ophthalmol. 1998 Oct;82(10):1154-8.PMID: 9924303 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.

    Souza Filho JP, Martins MC, Caissie AL, Torres VL, Fernandes LH, Erwenne CM, Burnier MN Jr.

    Clin Experiment Ophthalmol. 2005 Jun;33(3):279-84.PMID: 15932532 [PubMed - indexed for MEDLINE]Related articles

    10.

    Chemoreduction for unilateral retinoblastoma.

    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ.

    Arch Ophthalmol. 2002 Dec;120(12):1653-8.PMID: 12470138 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Conservative treatment in patients with unilateral retinoblastoma]

    Rutynowska-Pronicka O, Hautz W, Brozyna A, Dembowska-Bagińska B, Drogosiewicz M, Stypińska M, Perek D.

    Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Pt 1):655-63. Polish. PMID: 17317897 [PubMed - indexed for MEDLINE]Related articles

    12.

    Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis.

    Armenian SH, Panigrahy A, Murphree AL, Jubran RF.

    Pediatr Blood Cancer. 2008 Oct;51(4):479-84.PMID: 18478574 [PubMed - indexed for MEDLINE]Related articles

    13.

    Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.

    Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM.

    Arch Ophthalmol. 2001 Jan;119(1):41-8.PMID: 11146725 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Current therapeutic management in retinoblastoma with invasion of the optic nerve--a case report]

    Gavriş M, Neamţu S, Gavriş S, Ghiţuică A.

    Oftalmologia. 1999;46(1):69-71. Review. Romanian. PMID: 10641091 [PubMed - indexed for MEDLINE]Related articles

    15.

    Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma.

    Wilson MW, Rodriguez-Galindo C, Haik BG, Moshfeghi DM, Merchant TE, Pratt CB.

    Ophthalmology. 2001 Nov;108(11):2106-14; discussion 2114-5.PMID: 11713087 [PubMed - indexed for MEDLINE]Related articles

    16.

    Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.

    Marback EF, Arias VE, Paranhos A Jr, Soares FA, Murphree AL, Erwenne CM.

    Br J Ophthalmol. 2003 Oct;87(10):1224-8.PMID: 14507753 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Lack of correlation between the histologic and magnetic resonance imaging results of optic nerve involvement in eyes primarily enucleated for retinoblastoma.

    Wilson MW, Rodriguez-Galindo C, Billups C, Haik BG, Laningham F, Patay Z.

    Ophthalmology. 2009 Aug;116(8):1558-63. Epub 2009 Jul 9.PMID: 19545904 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treatment of intraocular retinoblastoma with vincristine and carboplatin.

    Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB.

    J Clin Oncol. 2003 May 15;21(10):2019-25.PMID: 12743157 [PubMed - indexed for MEDLINE]Related articles

    19.

    Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.

    Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.

    Pediatr Blood Cancer. 2008 Mar;50(3):567-72.PMID: 17729249 [PubMed - indexed for MEDLINE]Related articles

    20.

    Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.

    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.

    Ophthalmology. 2004 Oct;111(10):1917-24.PMID: 15465557 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity